Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-01-13 @ 5:17 PM
Study NCT ID:
NCT00242502
Status:
COMPLETED
Last Update Posted:
2013-05-06
First Post:
2005-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2011-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-10
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-18
First Submit QC Date:
None
Study First Post Date:
2005-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-02-19
Results First Submit QC Date:
None
Results First Post Date:
2013-05-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-25
Last Update Post Date:
2013-05-06
Last Update Post Date Type:
ESTIMATED